saffron, quercetin, ethylmethylhydroxypyridine malate, coenzyme Q10, abscisic acid, progesterone, lipoic acid, and progesterone, as neuroprotective agents in retinal degeneration situations.
Di Marco et al. [11] suggest that saffron may be a therapeutic coadjuvant in age-related macular degeneration (AMD) as it helps in maintaining retinal morphology, probably because of the antioxidant properties of some of its chemical components such as crocins, but also because it reduces metalloproteinase activation. The same authors suggest the beneficial actions of saffron in an experimental model of light-induced retinal degeneration [11] . Another substance suggested to be useful in ischemic retinopathies is the phytohormone, abscisic acid. Its role in modulating glucose metabolism, inflammation, and oxidative stress is reviewed by Baliño et al. [12] . Another drug that has shown to have protective effects in retinal ischemia is the new 3-hydroxypyridine derivative isomer of ethylmethylhydroxypyridine malate [13] .
Different animal models can be used to study retinitis pigmentosa (RP), a disease with no cure. Among the most used models are the light-induced retinal degeneration model and the rd1 and rd10. Koyama et al. [14] study the cytoprotective effect of quercetin via activator protein in Sprague Dawley rats with light-induced retinal damage. Hernández-Rabaza et al. [15] review how different drugs such as progesterone, lipoic acid, and sulforaphane are not able to correct the genetic alteration observed in different RP animal models but are able to decrease photoreceptor cell death rate. These results may be particularly important because they imply that patient blindness may be delayed several years. Another well-known antioxidant is coenzyme Q10; it has been shown to scavenge oxygen free and regenerate vitamin E. Beharry el al. [16] suggest that the administration of coenzyme Q10 reduces new retinal vascularization and at the same time improves astrocytes' morphology in a rat model of oxygen-induced retinopathy.
Nitric oxide (NO) is a gas molecule with diverse physiological and cellular functions in the retina, however, products generated from NO (i.e., dinitrogen trioxide (N2O3) and peroxynitrite) have great oxidative damaging effects. Cantó et al. [17] review the role of NO in several ocular diseases, such as diabetic retinopathy, retinitis pigmentosa, glaucoma, and AMD. The authors report that new therapies targeting nitrosative stress may be effective in retinal pathologies, nevertheless this has to be studied carefully because an excess of NO may also lead to undesired complications.
In conclusion, the studies regarding the use of antioxidants in retinal diseases are complex but support antioxidant supplements as therapeutic aids.
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